Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pulmonary Hypertension

  Free Subscription


Articles published in Am J Physiol Lung Cell Mol Physiol

Retrieve available abstracts of 70 articles:
HTML format



Single Articles


    March 2024
  1. PHILIP N, Yun X, Pi H, Murray S, et al
    Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2024;326:L252-L265.
    PubMed     Abstract available


    November 2023
  2. SIMPSON CE, Ambade AS, Harlan R, Roux A, et al
    Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2023;325:L617-L627.
    PubMed     Abstract available


    October 2023
  3. BARNES EA, Ito R, Che X, Alvira CM, et al
    Loss of Prolyl Hydroxylase 1 and 2 in SM22alpha-Expressing Cells Prevents Hypoxia-Induced Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2023 Oct 17. doi: 10.1152/ajplung.00428.2022
    PubMed     Abstract available


  4. LINGAPPAN K, Olutoye OO 2nd, Cantu A, Cantu Gutierrez ME, et al
    Molecular insights using spatial transcriptomics of the distal lung in congenital diaphragmatic hernia.
    Am J Physiol Lung Cell Mol Physiol. 2023;325:L477-L486.
    PubMed     Abstract available


    September 2023
  5. PANKOKE S, Schweitzer T, Bikker R, Pich A, et al
    Obesity impacts hypoxia adaptation of the lung.
    Am J Physiol Lung Cell Mol Physiol. 2023;325:L352-L359.
    PubMed     Abstract available


  6. ALMAZROUE H, Jin Y, Nelin LD, Barba JC 2nd, et al
    Human pulmonary microvascular endothelial cell DDAH1-mediated nitric oxide production promotes pulmonary smooth muscle cell apoptosis in co-culture.
    Am J Physiol Lung Cell Mol Physiol. 2023;325:L360-L367.
    PubMed     Abstract available


    August 2023
  7. MASSON B, Saint-Martin Willer A, Dutheil M, Penalva L, et al
    Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2023;325:L246-L261.
    PubMed     Abstract available


    June 2023
  8. DOUGHERTY EJ, Chen LY, Awad KS, Ferreyra GA, et al
    Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss.
    Am J Physiol Lung Cell Mol Physiol. 2023;324:L783-L798.
    PubMed     Abstract available


  9. SIMPSON CE, Coursen J, Hsu S, Gough EK, et al
    Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2023;324:L836-L848.
    PubMed     Abstract available


    May 2023
  10. BIGNARD J, Atassi F, Claude O, Ghigna MR, et al
    T-cell dysregulation and inflammatory process in Gcn2 (Eif2ak4(-/-))-deficient rats in basal and stress conditions.
    Am J Physiol Lung Cell Mol Physiol. 2023;324:L609-L624.
    PubMed     Abstract available


    April 2023
  11. GILBERT RM, Gleghorn JP
    Connecting clinical, environmental, and genetic factors point to an essential role for vitamin A signaling in the pathogenesis of congenital diaphragmatic hernia.
    Am J Physiol Lung Cell Mol Physiol. 2023;324:L456-L467.
    PubMed     Abstract available


    November 2022
  12. SURESH K
    Sex as a biologic variable: evidence from isolated lung endothelial cells.
    Am J Physiol Lung Cell Mol Physiol. 2022;323:L646-L647.
    PubMed    


    August 2022
  13. OSHITA H, Sawada H, Mitani Y, Tsuboya N, et al
    Perinatal hypoxia aggravates occlusive pulmonary vasculopathy in SU5416/hypoxia-treated rats later in life.
    Am J Physiol Lung Cell Mol Physiol. 2022;323:L178-L192.
    PubMed     Abstract available


    July 2022
  14. CAMPBELL NV, Mickael C, Kumar S, Zhang H, et al
    Single-cell RNA sequencing and binary hierarchical clustering define lung interstitial macrophage heterogeneity in response to hypoxia.
    Am J Physiol Lung Cell Mol Physiol. 2022;323:L58-L68.
    PubMed     Abstract available


    June 2022
  15. LEE MH, Sanders L, Kumar R, Hernandez-Saavedra D, et al
    Contribution of Fatty Acid Oxidation to the Pathogenesis of Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2022 Jun 28. doi: 10.1152/ajplung.00039.2022
    PubMed     Abstract available


    May 2022
  16. CHEN J, Rodriguez M, Miao J, Liao J, et al
    Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation.
    Am J Physiol Lung Cell Mol Physiol. 2022;322:L737-L760.
    PubMed     Abstract available


    March 2022
  17. MAARMAN GJ
    Reviewing the suitability of mitochondrial transplantation as therapeutic approach for pulmonary hypertension in the era of personalised medicine.
    Am J Physiol Lung Cell Mol Physiol. 2022 Mar 23. doi: 10.1152/ajplung.00484.2021
    PubMed     Abstract available


  18. LU M, Chen LY, Gairhe S, Mazer AJ, et al
    Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.
    Am J Physiol Lung Cell Mol Physiol. 2022;322:L315-L332.
    PubMed     Abstract available


    February 2022
  19. BAZAN IS, Ardito TA, Zhang Y, Shan P, et al
    Sex Differences and Altered Mitophagy in Experimental Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2022 Feb 9. doi: 10.1152/ajplung.00019.2020.
    PubMed     Abstract available


    October 2021
  20. JAIN PP, Lai N, Xiong M, Chen J, et al
    TRPC6, a Therapeutic Target for Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021 Oct 27. doi: 10.1152/ajplung.00159.2021
    PubMed     Abstract available


    September 2021
  21. DE MAN FS, Vonk-Noordegraaf A
    The magic of communication: the need to study organ and cell communication in pulmonary arterial hypertension-induced right heart failure.
    Am J Physiol Lung Cell Mol Physiol. 2021;321:L634-L636.
    PubMed    


    August 2021
  22. KASSA B, Kumar R, Mickael C, Sanders L, et al
    Endothelial Cell PHD2-HIF1alpha-PFKFB3 Contributes to Right Ventricle Vascular Adaptation in Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021 Aug 4. doi: 10.1152/ajplung.00351.2020.
    PubMed     Abstract available


  23. NAKAHARA M, Ito H, Skinner JT, Lin Q, et al
    The inflammatory role of dysregulated IRS2 in pulmonary vascular remodeling under hypoxic conditions.
    Am J Physiol Lung Cell Mol Physiol. 2021;321:L416-L428.
    PubMed     Abstract available


    July 2021
  24. WESTOO C, Norvik C, Peruzzi N, van der Have O, et al
    Distinct types of plexiform lesions identified by synchrotron-based phase-contrast micro-CT.
    Am J Physiol Lung Cell Mol Physiol. 2021;321:L17-L28.
    PubMed     Abstract available


    June 2021
  25. HYE T, Dwivedi P, Li W, Lahm T, et al
    Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021;320:L1025-L1037.
    PubMed     Abstract available


    May 2021
  26. AULAK KS, Al Abdi S, Li L, Crabb JS, et al
    Disease-specific platelet signaling defects in idiopathic pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021;320:L739-L749.
    PubMed     Abstract available


  27. WOODCOCK CC, Hafeez N, Handen A, Tang Y, et al
    Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
    Am J Physiol Lung Cell Mol Physiol. 2021;320:L726-L738.
    PubMed     Abstract available


    March 2021
  28. HADZIC S, Wu CY, Gredic M, Kojonazarov B, et al
    The effect of long-term doxycycline treatment in a mouse model of cigarette smoke-induced emphysema and pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021 Mar 24. doi: 10.1152/ajplung.00048.2021
    PubMed     Abstract available


  29. RICHTER MJ, Hsu S, Yogeswaran A, Husain-Syed F, et al
    Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021 Mar 3. doi: 10.1152/ajplung.00583.2020.
    PubMed     Abstract available


    January 2021
  30. VALUPARAMPIL VARGHESE M, James J, Rafikova O, Rafikov R, et al
    Glucose-6 Phosphate dehydrogenase deficiency contributes to metabolic abnormality and pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021 Jan 27. doi: 10.1152/ajplung.00165.2020
    PubMed     Abstract available


    December 2020
  31. SHRESTHA AK, Menon RT, El-Saie A, Barrios R, et al
    Interactive and independent effects of early lipopolysaccharide and hyperoxia exposure on developing murine lungs.
    Am J Physiol Lung Cell Mol Physiol. 2020;319:L981-L996.
    PubMed     Abstract available


    November 2020
  32. YUAN C, Chen HX, Hou HT, Wang J, et al
    Protein biomarkers and risk scores in pulmonary arterial hypertension associated with ventricular septal defect: integration of multi-omics and validation.
    Am J Physiol Lung Cell Mol Physiol. 2020;319:L810-L822.
    PubMed     Abstract available


    October 2020
  33. CALLEJO M, Mondejar-Parreno G, Morales-Cano D, Barreira B, et al
    Vitamin D deficiency downregulates TASK-1 channels and induces pulmonary vascular dysfunction.
    Am J Physiol Lung Cell Mol Physiol. 2020;319:L627-L640.
    PubMed     Abstract available


    September 2020
  34. SHEAK JR, Jones DT, Lantz BJ, Maston LD, et al
    NFATc3 Regulation of Collagen V Expression Contributes to Cellular Immunity to Collagen Type V and Hypoxic Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020 Sep 30. doi: 10.1152/ajplung.00184.2020
    PubMed     Abstract available


  35. TAN R, Li J, Liu F, Liao P, et al
    Phenylalanine Induces Pulmonary Hypertension Through Calcium-Sensing Receptor Activation.
    Am J Physiol Lung Cell Mol Physiol. 2020 Sep 23. doi: 10.1152/ajplung.00215.2020
    PubMed     Abstract available


  36. LAHM T
    Taking it to heart: dissecting cardiopulmonary interactions in diseases of the lung and the cardiovascular system.
    Am J Physiol Lung Cell Mol Physiol. 2020;319:L547-L549.
    PubMed    


  37. LIN Q, Johns RA
    Resistin family proteins in pulmonary diseases.
    Am J Physiol Lung Cell Mol Physiol. 2020;319:L422-L434.
    PubMed     Abstract available


  38. KRISHNAN S, Stearman RS, Zeng L, Fisher A, et al
    Transcriptomic modifications in developmental cardiopulmonary adaptations to chronic hypoxia using a murine model of simulated high-altitude exposure.
    Am J Physiol Lung Cell Mol Physiol. 2020;319:L456-L470.
    PubMed     Abstract available


    August 2020
  39. ALAM P, Agarwal G, Kumar R, Mishra A, et al
    Susceptibility to high-altitude pulmonary edema is associated with circulating miRNA levels under hypobaric hypoxia conditions.
    Am J Physiol Lung Cell Mol Physiol. 2020;319:L360-L368.
    PubMed     Abstract available


    June 2020
  40. SZULCEK R, Grune J, Kuebler WM
    The updated cancer paradigm of PAH: recognizing complexity.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L1111-L1114.
    PubMed    


  41. LEE JY, Francis CM, Bauer NN, Gassman NR, et al
    A cancer amidst us: the plexiform lesion in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L1142-L1144.
    PubMed    


  42. FRUMP AL, Lai YC, Lahm T
    Assessing the cancer hypothesis of pulmonary arterial hypertension: the devil is in the detail.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L1140-L1141.
    PubMed    


  43. CONDON D, Agarwal S, Chakraborty A, de Jesus Perez VA, et al
    The cancer hypothesis of pulmonary arterial hypertension: the next ten years.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L1138-L1139.
    PubMed    


  44. COOL CD, Kuebler WM, Bogaard HJ, Spiekerkoetter E, et al
    The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis-ten years later.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L1115-L1130.
    PubMed     Abstract available


    May 2020
  45. AGARWAL S, Sharma H, Chen L, Dhillon NK, et al
    NADPH oxidase-mediated endothelial injury in HIV- and opioid-induced pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L1097-L1108.
    PubMed     Abstract available


  46. GIE AG, Salaets T, Vignero J, Regin Y, et al
    Intermittent CPAP limits hyperoxia-induced lung damage in a rabbit model of bronchopulmonary dysplasia.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L976-L987.
    PubMed     Abstract available


    April 2020
  47. MORTY RE
    World health days in May 2020: Pulmonary hypertension, asthma, and tobacco-, smoking-, and vaping-related disease in focus.
    Am J Physiol Lung Cell Mol Physiol. 2020 Apr 1. doi: 10.1152/ajplung.00115.2020.
    PubMed    


  48. SHIMODA LA
    Know Your Enemy: Understanding the Pathophysiology of Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020 Apr 1. doi: 10.1152/ajplung.00111.2020.
    PubMed    


  49. CORRIS PA, Seeger W
    Call it by the correct name - pulmonary hypertension not pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020 Apr 1. doi: 10.1152/ajplung.00098.2020.
    PubMed    


    March 2020
  50. TUDER RM, Stenmark KR
    Perspective: Pathobiological paradigms in pulmonary hypertension, time for reappraisal.
    Am J Physiol Lung Cell Mol Physiol. 2020 Mar 18. doi: 10.1152/ajplung.00067.2020
    PubMed    


  51. JOSHI SR, Kitagawa A, Jacob C, Hashimoto R, et al
    Hypoxic Activation of G6PD Controls the Expression of Genes Involved in the Pathogenesis of Pulmonary Hypertension Through the Regulation of DNA Methylation.
    Am J Physiol Lung Cell Mol Physiol. 2020 Mar 11. doi: 10.1152/ajplung.00001.2020
    PubMed     Abstract available


  52. MCDOWELL RE, Aulak KS, Almoushref A, Melillo CA, et al
    Platelet glycolytic metabolism correlates with hemodynamic severity in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L562-L569.
    PubMed     Abstract available


    February 2020
  53. DIKALOVA A, Aschner JL, Kaplowitz MR, Cunningham G, et al
    Combined L-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs.
    Am J Physiol Lung Cell Mol Physiol. 2020 Feb 19. doi: 10.1152/ajplung.00280.2019
    PubMed     Abstract available


    January 2020
  54. ARJAANS S, Wagner BD, Mourani PM, Mandell EW, et al
    Early Angiogenic Proteins Associated with High Risk for Bronchopulmonary Dysplasia and Pulmonary Hypertension in Preterm Infants.
    Am J Physiol Lung Cell Mol Physiol. 2020 Jan 22. doi: 10.1152/ajplung.00131.2019
    PubMed     Abstract available


  55. HASHIMOTO R, Lanier GM, Dhagia V, Joshi S, et al
    Pluripotent HSCs Augment a-Adrenergic Receptor-Mediated Contraction of Pulmonary Artery and Contribute to the Pathogenesis of Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020 Jan 8. doi: 10.1152/ajplung.00327.2019.
    PubMed     Abstract available


  56. ELINOFF JM, Mazer AJ, Cai R, Lu M, et al
    Meta-analysis of blood genome-wide expression profiling studies in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L98-L111.
    PubMed     Abstract available


  57. NORVIK C, Westoo CK, Peruzzi N, Lovric G, et al
    Synchrotron-based phase-contrast micro-CT as a tool for understanding pulmonary vascular pathobiology and the 3-D microanatomy of alveolar capillary dysplasia.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L65-L75.
    PubMed     Abstract available


  58. BABICHEVA A, Ayon RJ, Zhao T, Ek Vitorin JF, et al
    MicroRNA-mediated downregulation of K(+) channels in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L10-L26.
    PubMed     Abstract available


    December 2019
  59. HE S, Ma C, Zhang L, Bai J, et al
    GLI1 mediated pulmonary artery smooth muscle cell pyroptosis contributes to hypoxia induced pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019 Dec 23. doi: 10.1152/ajplung.00405.2019
    PubMed     Abstract available


    November 2019
  60. CUSSAC LA, Cardouat G, Tiruchellvam Pillai N, Campagnac M, et al
    TRPV4 channel mediates adventitial fibroblast activation and adventitial remodeling in pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019 Nov 6. doi: 10.1152/ajplung.00084.2019.
    PubMed     Abstract available


    October 2019
  61. JALCE G, Guignabert C
    The Multiple Roles of Macrophage Migration Inhibitory Factor in Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019 Oct 2. doi: 10.1152/ajplung.00234.2019.
    PubMed     Abstract available


    August 2019
  62. PAUL T, Blanco I, Aguilar D, Tura-Ceide O, et al
    Therapeutic effects of soluble guanylate cyclase stimulation on pulmonary hemodynamics and emphysema development in guinea pigs chronically exposed to cigarette smoke.
    Am J Physiol Lung Cell Mol Physiol. 2019;317:L222-L234.
    PubMed     Abstract available


    July 2019
  63. CHANG CJ, Hsu HC, Ho WJ, Chang GJ, et al
    Cathepsin S promotes the development of pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019;317:L1-L13.
    PubMed     Abstract available


    June 2019
  64. HAO R, Song Y, Li R, Wu Y, et al
    MLN4924 protects against interleukin-17A-induced pulmonary inflammation by disrupting ACT1-mediated signaling.
    Am J Physiol Lung Cell Mol Physiol. 2019;316:L1070-L1080.
    PubMed     Abstract available


  65. KIPFMUELLER F, Heindel K, Geipel A, Berg C, et al
    Expression of soluble receptor for advanced glycation end products is associated with disease severity in congenital diaphragmatic hernia.
    Am J Physiol Lung Cell Mol Physiol. 2019;316:L1061-L1069.
    PubMed     Abstract available


    May 2019
  66. XIAO R, Zhu L, Su Y, Zhang J, et al
    Monocrotaline pyrrole induces pulmonary endothelial damage through binding to and release from erythrocytes in lung during venous blood reoxygenation.
    Am J Physiol Lung Cell Mol Physiol. 2019;316:L798-L809.
    PubMed     Abstract available


  67. HOGAN SE, Rodriguez Salazar MP, Cheadle J, Glenn R, et al
    Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019;316:L723-L737.
    PubMed     Abstract available


    March 2019
  68. MOURADIAN GC JR, Alvarez-Argote S, Gorzek R, Thuku G, et al
    Acute and chronic changes in the control of breathing in a rat model of bronchopulmonary dysplasia.
    Am J Physiol Lung Cell Mol Physiol. 2019;316:L506-L518.
    PubMed     Abstract available


  69. QUATREDENIERS M, Nakhleh MK, Dumas SJ, Courboulin A, et al
    Functional interaction between PDGFbeta and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019;316:L445-L455.
    PubMed     Abstract available


    January 2019
  70. RASHID J, Nozik-Grayck E, McMurtry IF, Stenmark KR, et al
    Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.
    Am J Physiol Lung Cell Mol Physiol. 2019;316:L119-L130.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.